Board committee changes Mediclinic International plc (Incorporated in England and Wales) Company Number 8338604 LSE Share Code: MDC JSE Share Code: MEI NSX Share Code: MEP ISIN: GB00B8HX8Z88 LEI: 2138002S5BSBIZTD5I60 (“Mediclinic” or “the Company”) 20 March 2017 BOARD COMMITTEE CHANGES The Company announces that, following a review of the composition of the Board Committees, the membership of the Committees will be as follows, with effect from 17 March 2017. - The Audit and Risk Committee will continue to be chaired by Desmond Smith and its other members will comprise Alan Grieve, Seamus Keating and Trevor Petersen. - The Remuneration Committee will continue to be chaired by Trevor Petersen and its other members will comprise Prof Dr Robert Leu and Seamus Keating. - The Nomination Committee will be chaired by Dr Edwin Hertzog and its other members will comprise Jannie Durand (with Pieter Uys as his alternate), Prof Dr Robert Leu, Trevor Petersen and Desmond Smith. - The Clinical Performance and Sustainability Committee will continue to be chaired by Dr Edwin Hertzog and its members will comprise Nandi Mandela, Danie Meintjes and Prof Dr Robert Leu. - The Investment Committee will continue to be chaired by Dr Edwin Hertzog and its other members will comprise Jannie Durand (with Pieter Uys as his alternate), Alan Grieve, Seamus Keating, Danie Meintjes and Jurgens Myburgh. Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia. Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom Website: www.mediclinic.com Corporate broker: Morgan Stanley & Co International plc JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd For further information please contact: Mediclinic International plc James Arnold, Head of Investor Relations ir@mediclinic.com Capita Company Secretarial Services Limited Victoria Dalby +44 (0)207 954 9600 Date: 20/03/2017 02:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.